Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | Inquiry | $ 1,023.00 |
Description | Monensin is an antiprotozoal agent produced by Streptomyces cinnamonensis. It has an inhibitory effect on the Wnt/β-catenin signaling cascade. Monensin is a prospective anticancer drug for the therapy of neoplasia with deregulated Wnt signaling. |
Synonyms | Elancoban, Rumensin |
Molecular Weight | 670.87 |
Formula | C36H62O11 |
CAS No. | 17090-79-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Monensin 17090-79-8 Elancoban Rumensin inhibitor inhibit